These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 15035450)

  • 21. Injection of acidic or neutral insulin and pain: a single-center, prospective, controlled, noninterventional study in pediatric patients with type 1 diabetes mellitus.
    Karges B; Muche R; Riegger I; Moritz M; Heinze E; Debatin KM; Wabitsch M; Karges W
    Clin Ther; 2006 Dec; 28(12):2094-101. PubMed ID: 17296465
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insulin pump treatment of childhood type 1 diabetes.
    Weinzimer SA; Sikes KA; Steffen AT; Tamborlane WV
    Pediatr Clin North Am; 2005 Dec; 52(6):1677-88. PubMed ID: 16301088
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Biphasic analog insulin instead of mixed insulin. Better adjustment, less hypoglycemia].
    MMW Fortschr Med; 2003 Jun; 145(24):56. PubMed ID: 12866308
    [No Abstract]   [Full Text] [Related]  

  • 24. Insulin detemir: new drug. A second long-acting insulin analogue: many uncertainties, few advantages.
    Prescrire Int; 2006 Oct; 15(85):163-7. PubMed ID: 17121210
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Oral and inhaled insulin: is it a breakthrough and what does it amount to?].
    Harsch IA; Fuchs FS; Hahn EG; Ficker JH
    Dtsch Med Wochenschr; 2001 Mar; 126(13):374-7. PubMed ID: 11332234
    [No Abstract]   [Full Text] [Related]  

  • 26. [Delayed action insulins. What is the value of insulin glargine in general practice?].
    MMW Fortschr Med; 2001 Apr; 143(16):54-6. PubMed ID: 11367996
    [No Abstract]   [Full Text] [Related]  

  • 27. The impact of insulin glargine on clinical and humanistic outcomes in patients uncontrolled on other insulin and oral agents: an office-based naturalistic study.
    Fischer JS; McLaughlin T; Loza L; Beauchamp R; Schwartz S; Kipnes M
    Curr Med Res Opin; 2004 Nov; 20(11):1703-10. PubMed ID: 15537471
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Insulin treatment. When, where and how should insulin be given?].
    Olsson PO
    Vardfacket; 1990 Feb; 14(3):II-VI. PubMed ID: 2188455
    [No Abstract]   [Full Text] [Related]  

  • 29. Twenty-four hour blood glucose profiles during insulin and insulin plus aprotinin subcutaneous administration in type I diabetes.
    Lunetta M; Napoli E; Sudano L; Leonardi R; Mughini L
    Horm Metab Res; 1986 Mar; 18(3):182-4. PubMed ID: 2422103
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Diabetes experts evaluate therapy with modern insulin analogs positively (interview by Dr. Silke Wedekind)].
    Renner R; Lundershausen R
    MMW Fortschr Med; 2013 May; 155(9):66-7. PubMed ID: 23951666
    [No Abstract]   [Full Text] [Related]  

  • 31. [Long acting insulin analogs: possibly more stable glucose regulation].
    van der Wal PS; van de Kraats GB
    Ned Tijdschr Geneeskd; 2004 Nov; 148(45):2248. PubMed ID: 15568633
    [No Abstract]   [Full Text] [Related]  

  • 32. [The absorption of short-acting insulin administered subcutaneously in diabetic patients].
    Nakamura T; Sekino K; Kasai F; Ishii F; Kudoo M; Imamura K; Kikuchi N; Takebe K
    Probl Endokrinol (Mosk); 1993; 39(2):14-6. PubMed ID: 8016042
    [No Abstract]   [Full Text] [Related]  

  • 33. [Early-morning hyperglycemia in patients with diabetes mellitus types 1 and 2].
    Jasik M
    Wiad Lek; 1989 Apr; 42(8):529-32. PubMed ID: 2697976
    [TBL] [Abstract][Full Text] [Related]  

  • 34. American Diabetes Association Resource Guide 2003. Insulin.
    Diabetes Forecast; 2003 Jan; 56(1):51-5. PubMed ID: 14765408
    [No Abstract]   [Full Text] [Related]  

  • 35. Long term safety and efficacy of intraperitoneal insulin infusion by means of implantable pumps.
    Pinget M; Jeandidier N
    Horm Metab Res; 1998 Aug; 30(8):475-86. PubMed ID: 9761375
    [No Abstract]   [Full Text] [Related]  

  • 36. Inhaled human insulin ((insulin human [rDNA origin]) Inhalation Powder) in diabetes mellitus.
    Mathieu C
    Expert Opin Drug Metab Toxicol; 2006 Oct; 2(5):779-91. PubMed ID: 17014394
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Insulin therapy in type 2 diabetes: short-acting insulin analog has advantages].
    MMW Fortschr Med; 2006 Jun; 148(26):56-7. PubMed ID: 16875384
    [No Abstract]   [Full Text] [Related]  

  • 38. [Borderline between ambulatory and stationary medicine in the example of diabetes].
    Mehnert H
    Dtsch Med Wochenschr; 1993 Jan; 118(1-2):38-41. PubMed ID: 8420770
    [No Abstract]   [Full Text] [Related]  

  • 39. Basal insulin switch from NPH to glargine in children and adolescents with type 1 diabetes.
    Päivärinta M; Tapanainen P; Veijola R
    Pediatr Diabetes; 2008 Jun; 9(3 Pt 2):83-90. PubMed ID: 18221431
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhaled insulin: Exubera.
    Odegard PS; Capoccia KL
    Ann Pharmacother; 2005 May; 39(5):843-53. PubMed ID: 15827072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.